795305-75-8

Upstream product

• 13992-15-9 phenyl-1-thio-α-D-glucopyranoside 
• 13992-16-0 Acetic acid (2R,3R,4S,5R,6R)-4,5-diacetoxy-6-acetoxymethyl-2-phenylsulfanyl-tetrahydro-pyran-3-yl ester 
• 302331-95-9 (2'S,3'S)-2,6-Di-O-benzyl-3,4-di-O-(2',3'-dimethoxybutane-2',3'-diyl)-D-glucono-1,5-lactone 
• 1004554-59-9 phenyl 3,4-O-[(2S,3R)-2,3-dimethoxybutane-2,3-diyl]-1-thio-α-D-glucopyranoside 

Downstream Products

• 882528-70-3 3,7-anhydro-4,8-di-O-benzyl-2-deoxy-D-glycero-D-gulo-octitol 

Relevant academic research and scientific papers

A systematic study of C-glucoside trisphosphates as myo-inositol trisphosphate receptor ligands. Synthesis of β-C-glucoside trisphosphates based on the conformational restriction strategy

β-C-Glucoside trisphosphates having a C2 side chain (3,7-anhydro-2-deoxy-D-glycero-D-gulo-octitol 1,5,6-trisphosphate, 11) and a C3 side chain (4,8-anhydro-2,3-dideoxy-D-glycero-D-gulo-nonanitol 1,6,7-trisphosphate, 12) were designed as structurally simpl

An efficient synthesis of β-C-glycosides based on the conformational restriction strategy: Lewis acid promoted silane reduction of the anomeric position with complete stereoselectivity

(Chemical Equation Presented) The reduction of glyconolactols having an anomeric carbon substituent by Et3SiH/TMSOTf proceeded with complete stereoselectivity to produce the corresponding β-C-glycosides when the substrates were conformationally restricted in the 4C 1-chair form by a 3,4-O-cyclic diketal or a 4,6-O-benzylidene protecting group. Thus, the efficient construction of β-C-glycosides was achieved on the basis of the conformation restriction strategy.